ArticleThe Journal of infectious diseases2024

Cerebrospinal Fluid Biomarkers of Neuronal/Glial Damage or Immune Activation Are Unsuitable for Assessing Post-COVID Cognitive Impairment.

No numbers read from the abstract.

Not cited yet